MARY HAMPTON: Open Payments
NPI 1366713828 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 9 payments from 5 companies in 2025. Trend: 2023 $1,059 · 2024 $1,587 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $84 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: DUPIXENT, TRELEGY ELLIPTA, NUCALA, OFEV, Adempas, AIRSUPRA.
Industry payments across KY — which companies pay providers there.
